Table 1.
Patient demographic baseline information
| Number of patients | Age (year) | BMI (kg/cm2) | Activity (MBq) | PSA (ng/ml) | Gleason score | Cr | Platelets (103/µl) | Site of metastases |
|---|---|---|---|---|---|---|---|---|
| 1 | 70 | 24 | 5920 | 40 | 5+5 | 1.08 | 198 | Skeletal |
| 2 | 63 | 21 | 6290 | 35.6 | 5+5 | 0.90 | 234 | Skeletal, lymph node |
| 3 | 77 | 23 | 5550 | 10 | 4+4 | 0. 81 | 158 | Skeletal |
| 4 | 72 | 24 | 7400 | 94 | 4+3 | 1.0 | 165 | Skeletal, lymph node |
| 5 | 72 | 25 | 5550 | 18.6 | 4+3 | 0.88 | 200 | Skeletal, lymph node |
| 6 | 85 | 24 | 5920 | 25 | 4+3 | 1.16 | 221 | Skeletal |
| 7 | 78 | 25 | 5550 | 55.8 | 5+3 | 2.02 | 199 | Skeletal, lung |
| 8 | 68 | 23 | 5550 | 74.4 | 4+3 | 1.23 | 256 | Skeletal, pelvic |
| 9 | 67 | 28 | 7400 | 7.6 | 4+4 | 1.09 | 217 | Skeletal, lymph node |
| 10 | 65 | 24 | 7400 | 31.2 | 5+5 | 1.12 | 323 | Skeletal, lung |
| Mean±SD | 71.4±6.07 | 24.01±1.79 | 6253±826.4 | 39.2±28.03 | 8.2±1.31 | 1.04±0.48 | 217±47 |
SD: Standard deviation, BMI: Body mass index, PSA: Prostate-specific antigen